CIOMS/RUCAM scale

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

The CIOMS/RUCAM scale is a tool to predict whether liver damage can be attributed to a particular medication.

Hepatotoxicity

Determining hepatotoxicity (toxic effects of a substance on the liver) remains a major challenge in clinical practice due to lack of reliable markers.^[1] Many other conditions lead to similar clinical as well as pathological picture. To diagnose hepatotoxicity, a causal relationship between the use of the toxin or drug and subsequent liver damage has to be established, but might be difficult, especially when idiosyncratic reaction is suspected.^[1] Simultaneous use of multiple drugs may add to the complexity. As in acetaminophen toxicity, well established dose dependent pharmacological hepatotoxicity is easier to spot.

Interpretation

The CIOMS/RUCAM scale has been proposed to establish causal relationship between offending drug and liver damage. The CIOMS/RUCAM scale involves a scoring system which categorizes the suspicion into "definite or highly probable" (score > 8), "probable" (score 6-8), "possible" (score 3-5), "unlikely" (score 1-2) and "excluded" (score ≤ 0). In clinical practice physicians put more emphasis on the presence or absence of similarity between the biochemical profile of the patient and known biochemical profile of the suspected toxicity ( e.g. cholestatic damage in amoxycillin-clauvonic acid ).^[1]

Elements of the scale

CIOMS/RUCAM scale

Type of liver injury	Hepatocellular		Cholestatic/mixed		Points
Time of onset of the event	first exposure	second exposure	first exposure	second exposure	—
Time from drug intake until reaction onset	5 to 90 days	1 to 15 days	5 to 90 days	1 to 90 days	+2
	<5 or >90 days	>15 days	<5 or >90 days	>90 days	+1
Time from drug withdrawal until reaction onset	≤15 days	≤15 days	≤30 days	≤30 days	+1
Risk factors	Alcohol		Alcohol or pregnancy		+1
	Age ≥ 55 years		Age ≥ 55 years		+1
Course of the reaction	>50% improvement 8 days		—		+3
	>50% improvement 30 days		>50% improvement 180 days		+2
	—		<50% improvement 180 days		+1
	Lack of information or no improvement		Lack of information or no improvement		+0
	Worsening or <50% improvement 30 days		—		-1

• Concomitant therapy:
  • Time to onset incompatible: +0
  • Time to onset compatible but with unknown reaction: -1
  • Time to onset compatible but known reaction: -2
  • Role proved in this case: -3
  • None or information not available: +0

• Exclusion of nondrug-related causes:
  • Rule out: +2
  • “Possible” to “not investigated”: -2 to +1
  • Probable: -3

• Previous information on hepatotoxicity:
  • Reaction unknown: +0
  • Reaction published but unlabeled: +1
  • Reaction labeled in the product's characteristics: +2

• Response to re-administration:
  • Positive: +3
  • Compatible: +1
  • Negative: -2
  • Not available or not interpretable: +0
  • or plasma concentration of drug known as toxic: +3
  • or validated laboratory test with high specificity, sensitivity, and predictive values:
    • Positive: +3
    • Negative: -3
    • Not interpretable or not available: +0

Score analysis

Points are summed and the total compared to this chart:

• 0 or lower: relationship with the drug excluded
• 1-2: unlikely
• 3-5: possible
• 6-8: probable
• >8: highly probable

If the results are incompatible with a connection, then the case is considered "unrelated". In some cases, insufficient information is available; these cases are recorded as "insufficiently documented".

See also

• Hepatotoxicity

References

WikiDoc Help Menu Quick Start.. Get Started Here! How to Login How to Search Pages How to Start a New Page How to Edit a Page Cheat Sheet Editing basics Learning Basic Formatting How to make Links in WikiDoc & to External Sites How to Make Lists How to Ignoring Formatting Adding References or Footnotes to Articles Tracking Changes You Have Made How to Put an Article Into a Category When Multiple Topics Should Go To The Same Page (MI, Acute MI, AMI) Using Redirection Advanced editing How to Make Tables How to Insert Images and Other Media How to Add Video Help:How to Make Columns Web Colors How To Make Templates How to Move Pages Inserting Dynamic Dates and Times Inserting WikiDoc Statistics Editing the Table of Contents Communicating your edits Let others know what you changed: The importance of Edit Summaries Minor Edits Edit Conflicts Help Videos You Can Watch Getting Started Video

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .